🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, multicenter, randomized, double-blinded, placebo-con...
Status
Completed
Location
Investigator site 77 - US0010086
Start Date
2020-12-01
Trial ID
NCT04598451
Treatments Being Tested
This study's purpose is to measure the treatment response from efgartigimod...
Status
Completed
Location
Neuromuscular Research Center
Start Date
2022-10-12
Trial ID
NCT05523167
Treatments Being Tested
The purpose of this study is to compare the effect and safety of rHuPH20 or...
Status
Completed
Location
Symbio Phase I Unit, Saint Anthony Memorial Research Center
Start Date
2009-06-23
Trial ID
NCT00928447
The purpose of this study is to compare the efficacy and safety of PEGylate...
Status
Terminated
Location
University of South Alabama
Start Date
2016-03-14
Trial ID
NCT02715804
ARGX-113-2009 is an operationally seamless 2-part, phase 2/3, prospective, ...
Status
Completed
Location
Investigator site 74 - US0010178
Start Date
2022-06-09
Trial ID
NCT05267600
Treatments Being Tested
The purpose of this study is to identify 1 or more doses of parenterally ad...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-03-21
Trial ID
NCT06310551
Phase 1B: Open label (all patients receive PEGPH20+gemcitabine), dose escal...
Status
Completed
Location
Highlands Oncology Group
Start Date
2011-09
Trial ID
NCT01453153
Treatments Being Tested
The objectives of this study are: * to establish the safety of subcutaneou...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00493220
Treatments Being Tested
This is a phase 1, first-in-human, double-blinded, randomized, placebo-cont...
Status
Completed
Location
Investigator Site 1
Start Date
2020-08-03
Trial ID
NCT04532125
Treatments Being Tested
This is an active control, randomized study to investigate the safety, tole...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-07-31
Trial ID
NCT04484337